Skip to Content

par 166 (Benztropine 2 mg)

Pill imprint par 166 has been identified as Benztropine mesylate 2 mg.

Benztropine is used in the treatment of extrapyramidal reaction; parkinson's disease; hyperhidrosis and belongs to the drug class anticholinergic antiparkinson agents. FDA has not classified the drug for risk during pregnancy. Benztropine 2 mg is not a controlled substance under the Controlled Substance Act (CSA).

Benztropine mesylate 2 mg par 166
Benztropine mesylate 2 mg par 166  Front
Benztropine mesylate 2 mg par 166  Back
Benztropine mesylate 2 mg par 166
Benztropine mesylate
par 166
2 mg
7.00 mm
Prescription only
Drug Class:
Anticholinergic antiparkinson agents
Pregnancy Category:
N - Not classified
CSA Schedule:
Not a controlled drug
Par Pharmaceutical Inc.
National Drug Code (NDC):
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
00182-1701 Goldline Laboratories Inc
00904-1057 Major Pharmaceuticals
63739-0035 McKesson Packaging Services
68115-0044 Dispensexpress Inc (repackager)
66336-0699 Dispensing Solutions Inc. (repackager)

Note: Inactive ingredients may vary.

View Details Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.